Range Low Price High Price Comment
30 days $5.90 $6.75 Wednesday, 1st May 2024 ADMA stock ended at $6.67. This is 2.30% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 3.45% from a day low at $6.53 to a day high of $6.75.
90 days $5.02 $6.75
52 weeks $3.06 $6.75

Historical ADMA Biologics Inc prices

Date Open High Low Close Volume
Feb 02, 2016 $5.79 $5.79 $5.79 $5.79 18 500
Feb 01, 2016 $6.01 $6.01 $6.01 $6.01 23 800
Jan 29, 2016 $6.04 $6.04 $6.04 $6.04 63 200
Jan 28, 2016 $5.96 $5.96 $5.96 $5.96 43 400
Jan 27, 2016 $6.04 $6.04 $6.04 $6.04 54 800
Jan 26, 2016 $6.37 $6.37 $6.37 $6.37 20 600
Jan 25, 2016 $6.15 $6.15 $6.15 $6.15 19 300
Jan 22, 2016 $6.09 $6.09 $6.09 $6.09 10 200
Jan 21, 2016 $6.00 $6.00 $6.00 $6.00 12 300
Jan 20, 2016 $6.03 $6.03 $6.03 $6.03 24 600
Jan 19, 2016 $5.91 $5.91 $5.91 $5.91 36 000
Jan 15, 2016 $6.07 $6.07 $6.07 $6.07 3 600
Jan 14, 2016 $6.05 $6.05 $6.05 $6.05 39 700
Jan 13, 2016 $6.37 $6.37 $6.37 $6.37 12 200
Jan 12, 2016 $6.71 $6.71 $6.71 $6.71 11 800
Jan 11, 2016 $6.69 $6.69 $6.69 $6.69 30 400
Jan 08, 2016 $7.15 $7.15 $7.15 $7.15 42 900
Jan 07, 2016 $7.62 $7.62 $7.62 $7.62 18 200
Jan 06, 2016 $7.65 $7.65 $7.65 $7.65 20 700
Jan 05, 2016 $7.92 $7.92 $7.92 $7.92 2 800
Click to get the best stock tips daily for free!

About ADMA Biologics Inc

ADMA Biologics ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the ... ADMA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT